| This week's sponsor is Biotech Primer. | |  | |
| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Wednesday, March 7, 2018 Sanofi finds itself in the middle of a very public legal battle with a former executive dismissed over sexual harassment even as the #MeToo movement builds momentum in the country. |
|
|
Top Stories Of The Week Tuesday, March 6, 2018 We started the Rotten Tomatoes special feature last year to spotlight companies that haven't followed through on the tough ethical and scientific demands of the biotech industry. This year, we’re at it again with a bit of a twist: We included companies bruised in 2016 but revived in 2017. Thursday, March 1, 2018 Because glioblastomas are heterogeneous, some cancer cells evade treatment and continue to grow. Gianpietro Dotti of the University of North Carolina is targeting a CAR-T antigen that is "highly prevalent" on glioblastomas to tackle this heterogeneity. Monday, March 5, 2018 The decision by Swiss drugmaker Lonza to move cell-therapy work out of a U.S. facility that was hit by an FDA warning letter last year will cost the plant about 125 jobs. Tuesday, March 6, 2018 UnitedHealthcare is planning to offer rebates directly back to millions of patients—a move that addresses a top criticism from the drug industry. Thursday, March 8, 2018 John Reed, M.D., Ph.D., is leaving Roche for personal reasons. William Pao, M.D., Ph.D., has stepped up to fill the head of Roche pharma research and early development (pRED) post vacated by Reed. Wednesday, March 7, 2018 While several classes of drugs have made HIV a manageable disease, there’s a small group of patients who develop resistance against multiple treatments. Now, the FDA has approved a Taiwanese company's new drug that can address that resistance. Wednesday, March 7, 2018 Big Pharma Novartis is teaming up with virtual clinical trial company Science 37 to boost the Swiss major’s ability to run “site-less” studies. Wednesday, March 7, 2018 Giuseppe Ciaramella, the leader of Moderna Therapeutics’ infectious diseases business, has jumped to a stealth-mode biotech startup, leaving a long list of clinical programs behind, according to STAT. Friday, March 2, 2018 Flex is teaming with Google to help healthcare device makers connect the information gathered by devices to Google Cloud. | This week's sponsor is Opal Group. | |  | |
|
|
